Archives

Exploring AI’s Potential to Transform Specialty Pharmacy 204 115 Shields Health Solutions

Exploring AI’s Potential to Transform Specialty Pharmacy
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Shields Health Solutions and UnityPoint at Home Extend Collaboration, Providing Patients and Families Enhanced Specialty Pharmacy Services 204 115 Shields Health Solutions

Shields Health Solutions and UnityPoint at Home Extend Collaboration, Providing Patients and Families Enhanced Specialty Pharmacy Services
Shields and UnityPoint at Home have expanded their partnership providing patients with complex, chronic conditions access to specialized pharmacy services designed to lower costs, broaden treatment options, enhance medication management, and improve overall health.
Hep-C Outcomes 2023 216 115 Shields Health Solutions

Hep-C Outcomes 2023

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) and is spread through contact with the blood of an infected person.

RA Outcomes 2023 216 115 Shields Health Solutions

RA Outcomes 2023

RA is an autoimmune and inflammatory disease where the immune system attacks healthy cells, causing inflammation and painful swelling in the affected parts of the body.

MS Outcomes 2023 216 115 Shields Health Solutions

MS Outcomes 2023

MS is a chronic, autoimmune disease of the central nervous system, affecting the communication between the brain and other parts of the body

Oncology Outcomes 2023 1024 1024 Shields Health Solutions

Oncology Outcomes 2023

Cancer, a genetic disease in which some of the body’s cells grow uncontrollably and spread to other parts of the body, is caused by changes to genes that control the…

Evaluation of a Social Determinants of Health Screening and Intervention Framework within an Integrated Health System Specialty Pharmacy Care Model Using a Closed-Loop Referral Process 216 115 Shields Health Solutions

Evaluation of a Social Determinants of Health Screening and Intervention Framework within an Integrated Health System Specialty Pharmacy Care Model Using a Closed-Loop Referral Process

This poster presents an evaluation of a social determinants of health screening and intervention framework within an integrated health system specialty pharmacy care model using a closed-loop referral process.    

Clinical Outcomes in Cystic Fibrosis Patients Enrolled in an Integrated Health System Specialty Pharmacy Care Model 216 115 Shields Health Solutions

Clinical Outcomes in Cystic Fibrosis Patients Enrolled in an Integrated Health System Specialty Pharmacy Care Model

This poster presents an evaluation of outcomes in cystic fibrosis (CF) patients within a health system specialty pharmacy care model by comparing them to established benchmarks.      

Clinical Outcomes of Migraine Patients Receiving Calcitonin Gene-Related Peptide Antagonists from an Integrated Health System Specialty Pharmacy 216 115 Shields Health Solutions

Clinical Outcomes of Migraine Patients Receiving Calcitonin Gene-Related Peptide Antagonists from an Integrated Health System Specialty Pharmacy

This poster evaluates the percent reduction in patient-reported monthly migraine days of patients receiving CGRPs from an integrated health system specialty pharmacy (HSSP).      

Impact of Integrated Health System Specialty Pharmacy Services on Inflammatory Bowel Disease Outcomes 216 115 Shields Health Solutions

Impact of Integrated Health System Specialty Pharmacy Services on Inflammatory Bowel Disease Outcomes

This poster presents an assessment of how health system specialty pharmacy (HSSP) services can improve clinical outcomes for IBD patients.